Literature DB >> 3394448

Epidemiology of meningococcal infections in the Federal Republic of Germany, 1966-1984.

U Berger1, H G Sonntag, C Ulbrich.   

Abstract

In the Federal Republic of Germany, the morbidity curve of meningococcal infections from 1966-1984 exhibited two maxima in 1970 and 1979 representing morbidity values of 2.9 and 2.3 per 100,000 of the population, and a small peak in 1974. The average morbidity of the 19 years was 2.1/10(5), the lowest morbidity 1.3/10(5) (1983/84). Meningitis occurred on an epidemic scale in 1970 in Bremen, in 1971 in Schleswig-Holstein and 1971-1977 in the Saarland. Most cases were notified during the first four four-week periods of the year, but in two years (1967, 1969), the late-summer peak exceeded the peak of winter/spring. 17.3% of the cases occurred in infants, 51.7% in the first five years of life. Morbidity was highest during the second quarter of the first year. The sex ratio (m:f) of the infections was 1.6:1, but in the aged, morbidity was about the same in both sexes (0.9:1). The case-fatality ratio varied between 7.1% (1977) and 12.1% (1971, 1982) and averaged at 9.7%. It was highest in the aged (37.1%) and second-highest in infants (18.7%). Differences of lethality due to sex could not be demonstrated. Of 1.685 meningococcal strains isolated from CSF and/or blood, 7.3% were of serogroup A, 74.4% of group B, 15% of group C, 1.5% of group Y and 1.1% of group W135. The proportion of group B infections was highest in infants, of group A infections in children (5-10 years), of group C infections in older children and adolescents (10-20 years). The sensitivity of N. meningitidis to sulfadiazine varied with serogroup and year of isolation. Since 1977, practically all group A strains, but only 13% of group B and 9% of group C strains proved to be resistant. Practically all strains were fully sensitive to rifampicin and minocycline; results of trials with spiramycin were not in support of the use of this compound as a chemoprophylactic agent.

Entities:  

Mesh:

Year:  1988        PMID: 3394448     DOI: 10.1016/s0176-6724(88)80118-4

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0176-6724


  4 in total

1.  Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination.

Authors:  R E Mandrell; W D Zollinger
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

2.  Epidemiology of meningococcal infections in children in mid-southern part of Turkey.

Authors:  E Alhan; N Bozdemir; B Yüksel; N Onenli; E Kocabaş; N Aksaray
Journal:  Eur J Epidemiol       Date:  1995-08       Impact factor: 8.082

3.  Antibody responses to the capsular polysaccharide of Neisseria meningitidis serogroup B in patients with meningococcal disease.

Authors:  D M Granoff; S K Kelsey; H A Bijlmer; L Van Alphen; J Dankert; R E Mandrell; F H Azmi; R J Scholten
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

4.  Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element.

Authors:  S Hammerschmidt; R Hilse; J P van Putten; R Gerardy-Schahn; A Unkmeir; M Frosch
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.